InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Pacira BioSciences, Inc.

PCRX Clue Score50
United States Fiscal year ends December CIK 0001396814 Results filed 4 Aug 2026
Add to watchlist

What the insiders did Mostly scheduled

Individual transactions

17
Insider
Date
Role
Action
Shares
Price
Amount
Lauren Riker
8 Oct 2026
Senior Vice President, Finance
Sold after exercise
6,000
$36.32
$217.92K
Jonathan Slonin
17 Aug 2026
Chief Medical Officer
Sold on a plan
3,040
$23.23
$70.62K
Lauren Riker
11 Jun 2026
Senior Vice President, Finance
Sold on a plan
6,115
$23.50
$143.70K
Kristen Williams
4 Jun 2026
Chief Administrative Officer
Sold on a plan
10,259
$22.27
$228.47K
Shawn Cross
23 Apr 2026
Chief Financial Officer
Sold after exercise
12,941
$25.16
$325.60K
Shawn Cross
22 Apr 2026
Chief Financial Officer
Sold after exercise
1,500
$25.01
$37.52K
Shawn Cross
21 Apr 2026
Chief Financial Officer
Sold after exercise
2,845
$25.01
$71.15K
Shawn Cross
20 Apr 2026
Chief Financial Officer
Sold after exercise
7,714
$25.14
$193.93K
Mark Froimson
17 Mar 2026
Director
Sell
500
$21.81
$10.91K
Jonathan Slonin
17 Mar 2026
Chief Medical Officer
Sold on a plan
3,261
$22.82
$74.42K
Kristen Williams
2 Feb 2026
Chief Administrative Officer
Sold on a plan
13,137
$20.53
$269.70K
Lauren Riker
2 Feb 2026
Senior Vice President, Finance
Sold on a plan
4,000
$20.81
$83.24K
Lauren Riker
5 Jan 2026
Senior Vice President, Finance
Sold on a plan
1,416
$24.24
$34.32K
Shawn Cross
10 Dec 2025
Chief Financial Officer
Sold after exercise
9,104
$25.14
$228.87K
Shawn Cross
9 Dec 2025
Chief Financial Officer
Sold after exercise
15,896
$25.03
$397.88K
Jonathan Slonin
17 Nov 2025
Chief Medical Officer
Sold on a plan
3,960
$24.09
$95.40K
Shawn Cross
10 Nov 2025
Chief Financial Officer
Sold on a plan
12,060
$22.09
$266.41K

What was left out

Form 4 filings counted 38
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 7
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 700,743
History held since 10 Feb 2011